Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 182

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele

Open access
Jochems, Caroline, Hodge, James W., Fantini, Massimo, Fujii, Rika, Morillon, Y. Maurice, Greiner, John W., Padget, Michelle R., Tritsch, Sarah R., Yok Tsang, Kwong, Campbell, Kerry S., Klingemann, Hans, Boissel, Laurent, Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Schlom, Jeffrey · 2016 · Oncotarget

Abstract

// Caroline Jochems 1, * , James W. Hodge 1, * , Massimo Fantini 1 , Rika Fujii 1 , Y. Maurice Morillon II 1 , John W. Greiner 1 , Michelle R. Padget 1 , Sarah R. Tritsch 1 , Kwong Yok Tsang 1 , Kerry S. Campbell 2 , Hans Klingemann 3 , Laurent Boissel 3 , Shahrooz Rabizadeh 4 , Patrick Soon-Shiong 3, 4 , Jeffrey Schlom 1 1 Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA 2 Immune Cell Development and Host Defense Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA 3 NantKwest, Inc., Culver City, CA, USA 4 NantCell, LLC, Culver City, CA, USA * These authors contributed equally to this work Correspondence to: Jeffrey Schlom, email: js141c@nih.gov Keywords: ADCC, NK lysis, immunotherapy, high affinity CD16, cetuximab Received: October 07, 2016 Accepted: November 07, 2016 Published: November 16, 2016 ABSTRACT Natural killer (NK) cells are known to play a role in mediating innate immunity, in enhancing adaptive immune responses, and have been implicated in mediating anti-tumor responses via antibody-dependent cell-mediated cytotoxicity (ADCC) by reactivity of CD16 with the Fc region of human IgG1 antibodies. The NK-92 cell line, derived from a lymphoma patient, has previously been well characterized and adoptive transfer of irradiated NK-92 cells has demonstrated safety and shown preliminary evidence of clinical benefit in cancer patients. The NK-92 cell line, devoid of CD16, has now been engineered to express the high affinity (ha) CD16 V158 FcγRIIIa receptor, as well as engineered to express IL-2; IL-2 has been shown to replenish the granular stock of NK cells, leading to enhanced perforin- and granzyme-mediated lysis of tumor cells. The studies reported here show high levels of granzyme in haNK cells, and demonstrate the effects of irradiation of haNK cells on multiple phenotypic markers, viability, IL-2 production, and lysis of a spectrum of human tumor cells. Studies also compare endogenous irradiated haNK lysis of tumor cells with that of irradiated haNK-mediated ADCC using cetuximab, trastuzumab and pertuzumab monoclonal antibodies. These studies thus provide the rationale for the potential use of irradiated haNK cells in adoptive transfer studies for a range of human tumor types. Moreover, since only approximately 10% of humans are homozygous for the high affinity V CD16 allele, these studies also provide the rationale for the use of irradiated haNK cells in combination with IgG1 anti-tumor monoclonal antibodies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.13411

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 182

Metadata

Authors
Jochems, C., Hodge, J. W., Fantini, M., Fujii, R., Morillon, Y. M., Greiner, J. W., Padget, M. R., Tritsch, S. R., Yok Tsang, K., Campbell, K. S., Klingemann, H., Boissel, L., Rabizadeh, S., Soon-Shiong, P., & Schlom, J.
Venue
Oncotarget
Published
2016-11-17
Volume
7
Issue
52
Pages
86359-86373
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2556149828
Cited by
182
References
4
FWCI
6.73
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele. https://app.cochat.ai/papers/10.18632/oncotarget.13411
The paper
Jochems, C., Hodge, J. W., Fantini, M., Fujii, R., Morillon, Y. M., Greiner, J. W., Padget, M. R., Tritsch, S. R., Yok Tsang, K., Campbell, K. S., Klingemann, H., Boissel, L., Rabizadeh, S., Soon-Shiong, P., & Schlom, J. (2016). An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele. Oncotarget. https://doi.org/10.18632/oncotarget.13411

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.